Research applications of Modified GRF 1-29 have demonstrated: Strong, dose-dependent GH pulse induction through pituitary GHRH receptor activation Preserved pulsatility natural GH secretion rhythms maintained without receptor blunting Elevated plasma IGF-1 concentrations following repeated dosing protocols Favorable half-life extension compared to native GHRH, without the continuous elevation of DAC-containing variants Compatibility with ghrelin-pathway secretagogues, enabling significant GH pulse amplification when co-administered with Ipamorelin No significant cortisol, prolactin, or ACTH stimulation at standard research concentrations Ipamorelin The Clean, Selective GH Secretagogue Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that functions as a potent, highly selective agonist of the ghrelin receptor (GHS-R1a)
Insurance coverage Each insurance plan has a list of covered drugs, also known as a drug formulary
Mechanical shear force from shaking can denature a peptide's secondary structure and permanently reduce its bioactivity
Our broad selection of dietary supplements are manufactured according to cGMP Standards to ensure the highest quality for manufacturing, packaging, labeling, and holding operations
Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity